December 8-9, 2011 FDA/CMS Summit
The Mayflower Renaissance, Washington DC Connect with top policy makers and executives – face-to-face – to develop personalized strategies and techniques that will drive your […]
Articles by Herina Ayot
Editor’s Note November 15, 2011
OneMedForum SF 2012 is around the corner and we are gearing up to present some of the most promising companies and technologies, as well as […]
PLC Medical Systems Uses Revenue in the EU to Fund Phase III Development in the US
Mark Tauscher, President and CEO of PLC Medical Systems Inc., discusses the company’s product RenalGuard, an important tool for ridding the body of toxins.
Special Panels Present Significant Opportunity at OneMedForum SF 2012
Panels consisting of leading strategic and financial investors will be followed by short presentations by promising companies. Over 100 companies will present.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Nov 30, – Dec 2, 2011 Therapeutic Area Partnerships
Westin Copley Place Boston, MA TA Partnerships delivers companies offering the high-value assets that your future sales demand – plus, you’ll also meet the companies […]
November 14, 2011 Brean Murray, Carret & Co. 2011 Life Sciences Summit
Brean Murray, Carret & Co. is a full-service, boutique investment bank dedicated to small cap and emerging growth companies and those who invest in them. […]
November 14-15 2011 Asian Healthcare Conference
In Credit Suisse’s 4th annual Asian Healthcare Conference this year, the focus is on both multinationals and local companies new development in the Asian healthcare […]
Neovasc Aims For CE Mark in 2012
OneMedRadio interviewed Alexei Marko, CEO and Director of Neovasc [CVE:NVC] where he discussed the company’s products for treating heart disease. The company’s flagship product The Reducer is in late stage development.